Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or dehydration—especially in those with hidden health issues.

ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

A WOMAN has shared the grim side effect from Mounjaro that’s so bad she’s thinking of stopping the drug altogether. Kelly, ...

A SLIMMING World Manager from Carlisle says slimming clubs are needed more than ever despite the growing popularity of weight loss medication.

I love how the GLP-1 medication subdues my appetite. It still seems miraculous to be able to say 'no' to cakes, desserts and ...